Jaime Rosenberg

During a Kaiser Family Foundation webcast, “Why are Health Prices So High, and What can be Done About Them?” stakeholders from varying sectors of the healthcare industry offered differing opinions on what is driving healthcare costs in the United States.

Common polygenic variation significantly contributes to the aggregation of migraine in families, whether they are common or rare subtypes.

Since March 2014, nearly 14,000 genetic tests have entered the market, with about 10 new tests appearing daily. A study published in Health Affairs sought to clarify unanswered questions surrounding genetic testing markets, test usage, and health policy implications.

The total cancer burden among people living with HIV will decrease from 8150 cases in 2010 to 6690 cases in 2030, and prostate and lung cancers will emerge as the most common types of cancer facing the patient population.

L.A. Care Health Plan—the nation’s largest publicly operated health plan serving 2 million low-income patients—is training physicians in their network to become better leaders and, in turn, improving quality of care and patient outcomes.

Since the Orphan Drug Designation program was passed in 1983, there have been over 600 orphan drug approvals, compared to less than 10 the decade before, said Stephen Jung, PharmD, BCPS, manager, drug information, MedImpact Healthcare Systems, during a session at the Academy of Managed Care Pharmacy’s Managed Care & Specialty Pharmacy Annual Meeting.

Aimee Tharaldson, PharmD, a senior clinical consultant in Emerging Therapeutics for Express Scripts, discusses specialty drugs that have recently been approved, and which we will likely see approved in the remainder of the year.

Combined, migraine-related absenteeism and presenteeism is responsible for 86 million lost workdays and costs £8.8 billion annually.

Patients with gaps between HIV primary care visits of 6 months up until 9 months did not have a significant difference in viral suppression loads. However, with gaps of 12 months or more, 23% of patients became unsuppressed.

Tisagenlecleucel, sold as Kymriah, has gained its second indication following the FDA's approval of the chimeric antigen receptor T-cell therapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma, the most common form of non-Hodgkin lymphoma.

Health insurance coverage gains since the enactment of the Affordable Care Act (ACA) in 2010 are starting to weaken and reverse, with the uninsured rate among those aged 19 to 64 increasing from 12.7% in 2016 to 15.5% in 2018.

Women with a past history of migraine have a 15% higher risk of developing hypertension than those with no history of migraine, according to study findings published in Cephalalgia.

The FDA has granted priority review to Merck’s supplemental Biologics License Application for pembrolizumab (Keytruda) in combination with pemetrexed (Alimta) and platinum chemotherapy as first-line treatment for patients with metastatic nonsquamous non–small cell lung cancer (NSCLC). The FDA is set to make a decision by September 23.

Researchers from the University of Massachusetts Medical School will test the safety and tolerability of a vaccine that may have the potential to prevent HIV infection.

Men are 3 times less likely to receive cancer genetic testing, owing largely to hereditary breast and ovarian cancer testing.

After 3 months of treatment with a single-pulse transcranial magnetic stimulation, patients averaged 3 fewer migraines per month, according to study findings.

At the Academy of Managed Care Pharmacy’s Managed Care & Specialty Pharmacy Annual Meeting, experts addressed the cost of treating patients with hemophilia and the importance of care coordination to ensure a more holistic approach toward caring for these patients.

Between 2000 and 2015, $562.6 billion was spent on HIV/AIDS, with most spending occurring in high-income and upper-income countries and out-of-pocket spending accounting for less than 10%, according to the first long-term, comprehensive analysis of funding for the disease.

Women account for over 75% of Americans who experience migraines, which could be attributable to the way that estrogen levels affect cells in the brain, according to new study findings.

Systematic cross-checking between physicians resulted in a 40% reduction in adverse events in the emergency department, according to a study published in JAMA Internal Medicine.

AIDSinfo, a portal from the National Institutes of Health, has outlined recent changes that have been made to the adult, adolescent, and perinatal HIV guidelines, including the incorporation of people-first language.

At the National Policy & Advocacy Summit on Biologics and Biosimilars, held in Washington, DC, on April 17, Congressman Earl “Buddy” Carter, R-Georgia, discussed the burden of the opioid epidemic, addressed the stigma surrounding addiction, and highlighted initiatives being taken to increase access to medication-assisted treatment and identify fraudulent prescriptions.

Amgen and Novartis announced full results from the LIBERTY trial, which assessed erenumab as preventive treatment for patients with episodic migraine who had previously failed on 2 to 4 treatments. The study met its primary endpoint and all of its secondary endpoints.

While calcitonin gene-related peptide (CGRP) inhibitors are projected to have a positive impact on the health of patients with chronic or episodic migraines for whom preventive therapy had failed relative to no treatment, it is likely that the inhibitors will exceed commonly-cited willingness-to-pay thresholds, according to a report from the Institute for Clinical and Economic Review (ICER).

The number of consumers enrolled in high-deductible health plans with health savings accounts (HSA-HDHPs) increased by 8% from 2016 to 2017, according to a report from America’s Health Insurance Plans.

Emergency departments can play a critical role in the identification of undiagnosed HIV in low-resource areas, according to a study published in PLOS ONE.

Researchers have identified genetic subtypes of diffuse large B-cell lymphoma that revise the molecular classification of the disease and could provide insight into why some patients respond to treatment and others don’t.

The Trump administration's proposal to extend the duration of short-term health plans would have a particularly significant impact on patients with cancer and cancer survivors, according to a webcast hosted by the National Coalition for Cancer Survivorship on Thursday.

The FDA has finalized 2 guidances to accelerate the development of next-generation sequencing (NGS)–based tests, the agency announced on Thursday. The guidances provide recommendations for designing, developing, and validating tests that use NGS.

ASCO last updated its guidelines on fertility preservation in 2013. Following the review of recent randomized controlled trials, systematic reviews, meta-analyses, and clinical practice guidelines, the panel made no significant changes to the 2013 recommendations: 2 recommendations for adult women were updated, and several clarifications to other recommendations were made.